Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension (NCT06832826) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension
Egypt60 participantsStarted 2024-01-14
Plain-language summary
The goal of this retrospective cohort study is to evaluate the risk of post-polypectomy bleeding following the colonoscopy resection of lower gastrointestinal polyps in patients with liver cirrhosis with portal hypertension. The main question it aims to answer is:
Does the risk of bleeding increase after colonoscopy polypectomy in patients with liver cirrhosis with portal hypertension?
Participants will be subjected to polypectomy of any colonic polyps.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All liver cirrhosis patients with portal hypertension and colonic polyps
Exclusion Criteria:
* Patients with platelet count less than 50,000/µL.
* Patients with hemoglobin levels less than 8 g/dL.
* Prothrombin Time more than 20 seconds.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial is specifically studying bleeding risks after colon polyp removal in people with cirrhosis and portal hypertension, how does my own liver disease severity and portal hypertension affect my personal risk of bleeding if I need a polypectomy?
2This study is looking at two types of bleeding — one that happens right away during or after the procedure and one that's delayed — so what signs of delayed bleeding should I watch for at home, and how quickly would I need to seek care if they happen?
3The trial is no longer actively recruiting, which means data may already be collected — are there any early findings or published results my doctor is aware of that could inform how my polypectomy should be handled given my cirrhosis?
4Given that this trial is specifically designed to study whether it's safe to do polypectomies in cirrhotic patients with portal hypertension, does my doctor currently have enough confidence in the safety of this procedure for someone with my condition, or would it be safer to monitor the polyps without removing them for now?
5Are there any special techniques or precautions — like clipping, different removal methods, or adjusted medications — that this trial is evaluating that my doctor could consider using during my procedure to reduce my bleeding risk?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.